Why the study?
The study was conducted to compare the quality and acceptability of the Chronic Headache Quality of Life Questionnaire (CHQLQ) with the Headache Impact Test (HIT-6) in people meeting an epidemiological definition of chronic headaches.
Does the Chronic Headache Quality of Life Questionnaire (CHQLQ) compare favorably to the Headache Impact Test (HIT-6) in measuring health-related quality of life in people with chronic headaches?
Does the Chronic Headache Quality of Life Questionnaire (CHQLQ) compare favorably to the Headache Impact Test (HIT-6) in measuring health-related quality of life in people with chronic headaches?
Both the CHQLQ and HIT-6 are reliable and responsive measures for assessing health-related quality of life in chronic headache patients, with CHQLQ offering added relevance through emotional wellbeing items.
CHQLQ offers comparable psychometrics to HIT-6 with greater patient relevance; supports further validation before routine use in chronic headache.
OBJECTIVE: To compare the quality and acceptability of a new headache-specific patient-reported measure, the Chronic Headache Quality of Life Questionnaire (CHQLQ) with the six-item Headache Impact Test (HIT-6), in people meeting an epidemiological definition of chronic headaches. METHODS: Participants in the feasibility stage of the Chronic Headache Education and Self-management Study (CHESS) (n = 130) completed measures three times during a 12-week prospective cohort study. Data quality, measurement acceptability, reliability, validity, responsiveness to change, and score interpretation were determined. Semi-structured cognitive interviews explored measurement relevance, acceptability, clarity, and comprehensiveness. RESULTS: Both measures were well completed with few missing items. The CHQLQ's inclusion of emotional wellbeing items increased its relevance to participant's experience of chronic headache. End effects were present at item level only for both measures. Structural assessment supported the three and one-factor solutions of the CHQLQ and HIT-6, respectively. Both the CHQLQ (range 0.87 to 0.94) and HIT-6 (0.90) were internally consistent, with acceptable temporal stability over 2 weeks (CHQLQ range 0.74 to 0.80; HIT-6 0.86). Both measures responded to change in headache-specific health at 12 weeks (CHQLQ smallest detectable change (improvement) range 3 to 5; HIT-6 2.1). CONCLUSIONS: ISRCTN79708100. Registered 16th December 2015, http://www.isrctn.com/ISRCTN79708100.
No takes yet. Share an insight, caveat, or question.
Haywood et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: